ASPI
ASP Isotopes Inc. Common StockBasic Materials · $340M market cap
Verdict
We can't put a fair value on ASPI right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow ASPI
Track it on your watchlist and see the full analysis. Free.
Create a free accountSuperinvestors
1 of the investors we track holds ASPI. In Q2 2026, 1 added. Who we track
Moves in Q2 2026
Added: Polen Capital Management
Insider activity
Since Sep 2, 2026: 1 open-market purchase worth $22K and 6 sales worth $1.2M. Why purchases matter
Purchases
Sales
Ainscow Robert
COO · 2026-09-08
Sold
$36K
Mann Paul Elliot
Chairman and CEO · 2026-09-04
Sold
$343K
Mann Paul Elliot
Chairman and CEO · 2026-09-03
Sold
$328K
Mann Paul Elliot
Chairman and CEO · 2026-09-02
Sold
$327K
Ainscow Robert
COO · 2026-09-02
Sold
$98K
Show all 6 salesShow fewer
Ainscow Donald George
EVP, Gen Counsel, Secretary · 2026-09-02
Sold
$92K
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP…
Chemicals - Specialty
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works